Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Bimatoprost eye drops 0.03% |
| Brinzolamide + brimonidine eye drop 1% + 0.2% |
| Brinzolamide + timolol eye drops 1% + 0.5% |
| Brinzolamide eye drop 1% |
| Carbetocin Injection 100 microgram/mL |
| Carbomer 980 eye drops 0.2%, 0.6mL x 30 ’minims’ |
| Ciprofloxacin eye drops 0.3% |
| Elranatamab injection (subcutaneous) 44 mg/1.1 mL, 76 mg/1.9 mL |
| Esketamine nasal spray 28 mg/2 actuations |
| Mometasone nasal spray 50 microgram/actuation |
| Tamsulosin modified release tablet 400 microgram |
| Teprotumumab injection 500 mg |
Amendments
| Aflibercept Injection 2 mg/0.05 mL (3.6 mg/0.09 mL) syringe |
| Aflibercept Injection 8 mg/0.07 mL (21 mg/0.184 mL), syringe |
| Aflibercept Injection 8 mg/0.07 mL (30.1 mg/0.263 mL), vial |
| Amphotericin B lozenge 10mg |
| Dorzolamide + timolol eye drop 2% + 0.5% |
| Dorzolamide eye drop 2% |
| Estradiol modified release pessary 10 microgram |
| Latanoprost + timolol eye drop 0.005% + 0.5% |
| Latanoprost eye drop 0.005% |
| Lidocaine Gel 2% Syringe |
| Mifepristone & Misoprostol (combination pack - 200 mg & 200 microgram [MS 2-Step®]) |
| Mupirocin 2% nasal ointment 5g |
| Timolol eye drop 0.5% |
| Travoprost + timolol eye drop 0.004% + 0.5% |
| Travoprost eye drop 0.004% |
Deletions
| Aflibercept injection 2 mg/0.05 mL (4 mg/0.1 mL) vial |
| Apraclonidine eye drop 0.5%, 10 mL |
| Artificial saliva liquid 2 Litres |
| Betaxolol eye drops 0.5% |
| Carbachol eye drops 1.5% 15mL |
| Carbochol eye drops 3% |
| Pilocarpine eye drops 0.125% 15mL |
| Pilocarpine eye drops 3% |
| Sodium cromoglycate 2% eye drops |
| Timolol eye drop 0.25% |